ClinicalTrials.gov record
Completed Phase 2 Interventional

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

ClinicalTrials.gov ID: NCT00001059

Public ClinicalTrials.gov record NCT00001059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 3:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison Study of Liposomal Doxorubicin With or Without Bleomycin and Vincristine for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma

Study identification

NCT ID
NCT00001059
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
120 participants

Conditions and interventions

Interventions

  • Bleomycin sulfate Drug
  • Doxorubicin hydrochloride (liposomal) Drug
  • Filgrastim Drug
  • Vincristine sulfate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jul 31, 1998
Last update posted
Apr 16, 2012

Ends 1998

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294
USC CRS Los Angeles California 90033
UCLA CARE Center CRS Los Angeles California 90095
Ucsf Aids Crs San Francisco California
University of Colorado Hospital CRS Aurora Colorado 80262
Univ. of Miami AIDS CRS Miami Florida 33136
Queens Med. Ctr. Honolulu Hawaii 96813
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Northwestern University CRS Chicago Illinois 60611
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 46202
Bmc Actg Crs Boston Massachusetts 02118
Beth Israel Deaconess - East Campus A0102 CRS Boston Massachusetts 02215
Massachusetts General Hospital ACTG CRS Boston Massachusetts
Washington U CRS St Louis Missouri 63110
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14215
Memorial Sloan-Kettering Cancer Ctr. New York New York 10021

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2012 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →